MAPT and Alzheimer disease: Evaluation of [&lt;sup&gt;18&lt;/sup&gt;F]MK-6240 binding to tau protein in postmortem human brains of Down syndrome and Alzheimer's disease and assessment of off-target (non-tau) binding.